Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Cars.com
CARS
5
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
US Stock MarketDetailed Quotes
INO Inovio Pharmaceuticals
- 1.560
- -0.030-1.89%
Close Apr 4 16:00 ET
- 1.570
- +0.010+0.64%
Post 19:57 ET
57.20MMarket Cap-0.39P/E (TTM)
1.580High1.500Low608.98KVolume1.580Open1.590Pre Close939.47KTurnover1.84%Turnover RatioLossP/E (Static)36.67MShares13.44052wk High0.84P/B51.64MFloat Cap1.47052wk Low--Dividend TTM33.10MShs Float2352.000Historical High--Div YieldTTM5.03%Amplitude1.470Historical Low1.542Avg Price1Lot Size
About Inovio Pharmaceuticals Company
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Company Profile
SymbolINO
Company NameInovio Pharmaceuticals
Listing DateDec 8, 1998
Founded1983
CEODr. Jacqueline E. Shea
MarketNASDAQ
Employees134
Fiscal Year Ends12-31
Address660 West Germantown Pike,Suite 110
CityPlymouth Meeting
ProvincePennsylvania
CountryUnited States of America
Zip Code19462-1111
Phone1-267-440-4200
Websitehttp://www.inovio.com
Company Executives
- Name
- Position
- Salary
- Dr. Jacqueline E. Shea
- President, Chief Executive Officer and Director
- 2.07M
- Michael John Sumner
- Chief Medical Officer
- --
- Dr. Laurent Humeau, PhD
- Chief Scientific Officer
- 976.66K
- Peter D. Kies
- Chief Financial Officer and Principal Accounting Officer
- 988.73K
- Simon X. Benito
- Chairman of the Board
- 151.19K
- Dr. David B. Weiner, PhD
- Director
- 201.79K
- Wendy L. Yarno, M.B.A.
- Independent Director
- 123.69K
- Lota S. Zoth, C.P.A.
- Independent Director
- 118.69K
- Jay P. Shepard
- Independent Director
- 119.31K
- Dr. Roger D. Dansey, M.D.
- Independent Director
- 108.69K
- Dr. Ann C. Miller, M.D.
- Independent Director
- 126.94K
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
